FDA Finds Violations At Dr. Pepper Snapple Bottling Plant

Law360, New York (October 2, 2012, 4:55 PM EDT) -- The U.S. Food and Drug Administration has uncovered health violations at a Dr. Pepper Snapple Group Inc. subsidiary's bottling plant, concluding that the company's lemon and lime juices have been prepared or stored under insanitary conditions, according to a letter the agency released Tuesday.

The FDA's inspection of American Bottling Co. Inc.'s plant in March revealed "serious violations" of the agency's Hazard Analysis & Critical Control Points regulation system for juice, according to the letter, which was sent to the company in July. The conditions at...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.